Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction

March 8, 2022 updated by: Chang Gung Memorial Hospital

Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction: a Prospective Double-blind Randomized Controlled Trial

Adhesive small bowel obstruction (ASBO) is one of the most common complications and is a major cause of admission after intra-abdominal surgery. To date, the ideal management of ASBO remains controversial. The aim of this protocol designed as a double-blind randomized controlled trial is to investigate the efficacy of laser acupuncture (LA) therapy in patients with ASBO.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

92

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kaohsiung, Taiwan, 833
        • Recruiting
        • Kaohsiung Chang Gung Memorial Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 20 to 80 years
  • Clinical symptoms and signs of mechanical obstruction

Exclusion Criteria:

  • Clear non-adhesive etiology of small bowel obstruction (e.g. tumor, hernia)
  • Emergency surgical intervention before being admitted to the hospital
  • Pregnancy
  • Local skin infection on the acupoints, and limb amputees.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Control group
The subjects in the control group will receive sham LA treatment, without any laser output (no stimulation) at the same acupoints used in experimental group.
Laser acupuncture is a non-invasive therapy that involves stimulation of traditional acupoints with low-intensity, non-thermal laser irradiation.
Experimental: LA group
The subjects in the experimental group will receive 0.375 J of energy at each of the following acupoints: LI4 (Hegu, B3), PC6 (Neiguan, B3), ST25 (Tianshu, B3), ST36 (Zusanli, B2), CV4 (Guanyuan), CV12 (Zhongwan, B3).
Laser acupuncture is a non-invasive therapy that involves stimulation of traditional acupoints with low-intensity, non-thermal laser irradiation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success rate of conservative treatment
Time Frame: 2 week
Defined as no need for long term nasogastric tube decompression and operative intervention.
2 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to oral intake
Time Frame: 2 weeks
Defined as participants can try intake due to symptoms improved including nausea, vomiting, distension and pain.
2 weeks
Length of hospital stay
Time Frame: Through study completion, an average of 1 year
Date from admission to discharge
Through study completion, an average of 1 year
Serum lipase
Time Frame: Up to 2 weeks
Serum lipase
Up to 2 weeks
Serum amylase
Time Frame: Up to 2 weeks
Serum amylase
Up to 2 weeks
Serum cortisol
Time Frame: Up to 2 weeks
Serum cortisol
Up to 2 weeks
Serum motilin
Time Frame: Up to 2 weeks
Serum motilin
Up to 2 weeks
Serum ghrelin
Time Frame: Up to 2 weeks
Serum ghrelin
Up to 2 weeks
Serum intestinal fatty acid binding protein (I-FABP)
Time Frame: Up to 2 weeks
Serum intestinal fatty acid binding protein (I-FABP)
Up to 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chun-Ting Liu, MD, Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Anticipated)

February 28, 2023

Study Completion (Anticipated)

February 28, 2023

Study Registration Dates

First Submitted

March 16, 2020

First Submitted That Met QC Criteria

March 22, 2020

First Posted (Actual)

March 24, 2020

Study Record Updates

Last Update Posted (Actual)

March 10, 2022

Last Update Submitted That Met QC Criteria

March 8, 2022

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adhesive Small Bowel Obstruction

Clinical Trials on Laser acupuncture

Subscribe